Effect of oral supplement of carnitine on hypoglycemia, sepsis and apnea of very low birth weight neonates
Phase 2
- Conditions
- Carnitine supplementation in very low birth weight neonates.
- Registration Number
- IRCT138707281162N6
- Lead Sponsor
- Mashhad University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Inclusion/Exclusion:
Neonates with appropriate for gestational age, birth weight < 1500g, in 3 days of life, without cardiovascular disease, congenital anomaly and respiratory or metabolic diseases.
Exclusion: History of diabetes, hypertension, preeclampsia or long fever in mother. Mechanical ventilation, severe hypotension, shock, metabolic disease during the intervention for neonates.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Septicemia. Timepoint: Daily. Method of measurement: Positive blood culture.;Hypoglycemia (serum glucose less than 40 mg/dl). Timepoint: daily. Method of measurement: glucometer.;Apnea. Timepoint: Daily. Method of measurement: Number of apnea episodes (by pulsoximetry).
- Secondary Outcome Measures
Name Time Method Duration of admission in hospital. Timepoint: dailly. Method of measurement: Number of hospitalization days.